Baobab

Baobab (Adansonia digitata L.)

1. Identity, Botanical Classification, and Natural Source

Binomial name: Adansonia digitata L. (family Malvaceae, formerly placed in Bombacaceae).

Adansonia digitata L. is an indigenous fruit tree associated with the Savannah drylands of sub-Saharan Africa. The tree is often called the "Tree of Life," the "monkey bread tree," the "cream of tartar tree," or "the upside-down tree" due to its distinctive silhouette of root-like branches. It produces a large, gourd-shaped fruit containing a soft, powdery pulp and kidney-shaped seeds. Unlike most fruits, baobab fruit naturally dries while still on the branch — the pulp dehydrates to approximately 10–14% moisture content inside the hard shell — requiring minimal processing to produce a shelf-stable powder.

The tree favors a dry, woodland habitat with rocky, well-drained soil. Baobab is a slow-growing tree; carbon-dating techniques and analyses of core samples suggest that baobab trees with 10-meter diameters may be around 2,000 years old.

The genus Adansonia contains eight species distributed across Africa, Madagascar, and Australia, but A. digitata is the only species native to mainland sub-Saharan Africa and the predominant species in commerce. The seven other species are largely endemic to Madagascar (A. grandidieri, A. madagascariensis, and others) or Australia (A. gregorii), and they are not the subject of the mainstream supplement market.

Plant Parts Used Commercially

• Fruit pulp (dried powder): The most commercially important part, produced as a shelf-stable cream-colored powder directly from the naturally dried pulp inside the hard fruit shell.
• Leaves: Typically sun-dried and either stored as whole leaves or pounded and sieved into a fine powder; young leaves are widely used, cooked as spinach, and frequently dried, often powdered and used for sauces over porridges, thick gruels of grains, or boiled rice.
• Seeds and seed oil: The seed oil and protein are evaluated for their fatty acid profile; the seed is a good source of energy, protein, and fat; the fatty acid profile shows oleic and linoleic as the major unsaturated fatty acids, while palmitic is the major saturated acid.
• Bark: The bark has astringent properties and has been used traditionally to alleviate colds, fevers, and influenza.

Common Commercial Forms and Preparations

• Fruit pulp powder: The dominant commercial form in Western markets. In 2008, the European Commission included the pulp in the European Union's list of novel food ingredients, and in 2009, the U.S. Food and Drug Administration recognized it as a food ingredient.
• Aqueous beverages: Prepared by dissolving the powder in water. Local people soak the pulp in very cold water to make a refreshing beverage called "bouye."
• Seed oil: Cold-pressed from the seeds for cosmetic and culinary applications.
• Leaf powder and leaf sauce: Dried leaf powder used as a culinary thickener and nutritional supplement, especially in West and Central Africa.

2. Traditional and Historical Use

Baobab has a long history of use as a medicinal product. The botanist and physician Prospero Alpini (1553–1617) wrote in his book De plantis Aegypti liber that fresh baobab fruit had a very pleasing taste, and that the Ethiopians used it on burns and rashes and to cool the effects of serious fevers. For these afflictions, they either chewed the flesh of the fruit or pressed it into a juice with added sugar.

Alpini also wrote that in Cairo, Egypt, where fresh baobab fruit was unobtainable, Egyptians made preparations from its powder to treat fevers, dysentery, and bloody wounds.

Ethnopharmacological uses of various plant parts have been reported for hydration, antipyretic, antiparasitic, antitussive, and sudorific properties and also in the treatment of diarrhea and dysentery in many African countries.

The bark, roots, leaves, fruits, and seeds of baobab are widely used by indigenous peoples for human and animal medicines. Specific documented ethnomedicinal uses across sub-Saharan African cultures include the following:

• Fever and febrile illness: A decoction made from the fresh bark is taken as a beverage for one week to treat flu.
• Diarrhea and dysentery: The fruit pulp and powdered seeds are used in cases of dysentery and to promote perspiration.
• Malaria and other infections: Specific documented uses include the treatment of malaria, tuberculosis, fever, microbial infections, diarrhea, anaemia, dysentery, and toothache.
• Dental use: Oil extracted from the seeds is used for inflamed gums and to ease diseased teeth.
• Food thickening and cosmetics: Due to its high pectin content, the pulp has also been used traditionally as a thickening agent for sauces and jams. In some African cultures, the pulp has been used as an ingredient in cosmetics.
• Nutrition and food security: Local communities mainly utilize the leaves, pulp, and seeds of baobab as a source of food and for income generation.

The baobab fruit has been consumed in Africa safely for thousands of years, according to ethnobotanists specializing in African plants used for food and medicine.

3. Key Constituents and Active Compounds

Macronutrients

Characterization of baobab fruit pulp has shown the presence of all macronutrients: protein (3.95 g/100 g), lipid (12.11 g/100 g), carbohydrate (57.62 g/100 g), vitamin C (494.94 mg/100 g DM), fibre (8.17 g/100 g), and minerals including calcium (333.75 mg/100 g), magnesium (167.45 mg/100 g), phosphorus (61.20 mg/100 g), and potassium (2670.05 mg/100 g). Nutritional values vary substantially by geographic origin; there is significant variation in pulp moisture, protein, fiber, ash, and elemental content among provenances, and the highest mean pulp crude fiber (8.68 g/100 g dw) was recorded in Kenya. In Angola, samples from the Camucuio municipality showed higher fibre content (56.62 g/100 g) and vitamin C (288.9 mg/100 g).

Polyphenols and vitamin C content provide baobab pulp a soluble antioxidant capacity similar to or even higher than commonly consumed fruits such as apples, kiwis, strawberries, and oranges. Its fiber content is about 70–80% of the dry mass, with pectin being the most abundant fiber.

Vitamin C (Ascorbic Acid)

The fresh fruit pulp of indigenous baobab trees contains a high amount (>200 mg/100 g) of vitamin C, which is unparalleled compared to vegetables and other fruits. Baobab has also been reported to contain a high content of vitamin C at 466 mg/100 g in some analyses. These figures vary considerably by sample origin.

Minerals

Both the kernel and the pulp contain substantial quantities of calcium, potassium, and magnesium. At country level, Malawi has been reported to show the highest mean pulp potassium (22.2 mg/g), calcium (4,300 mg/kg), magnesium (2,300 mg/kg), sodium (1,000 mg/kg), and phosphorus (1,100 mg/kg). Kenya has been recorded with the highest mean pulp iron (57.4 µg/g) and manganese (27.2 µg/g).

Polyphenols and Flavonoids

The health benefits of baobab have been attributed to its bioactive compounds, namely phenols, flavonoids, proanthocyanins, tannins, catechins, and carotenoids.

Fifteen specific compounds have been identified in baobab fruit pulp by HPLC-ESI-MS/MS; these include: citric acid; phenolic acid feruloylquinic acid; two flavan-3-ols, catechin and epicatechin, and their oligomers procyanidin dimer I and II, procyanidin trimer I and II; and six flavonol glycosides including quercetin 3-O-glucoside, kaempferol 3-O-galactoside, kaempferol 3-O-glucoside, and tiliroside.

Baobab fruit pulps are found to be rich in procyanidins and flavonol glycosides, with tiliroside as the major constituent.

Baobab fruit, particularly the pulp, has been found to contain phenolic compounds including gallic acid, quercetin, rutin, catechin, and proanthocyanidins, as well as fatty acids.

Organic Acids

Adansonia digitata fruit contains organic acids such as citric, tartaric, malic, and succinic acids, and its seeds yield oil that contains oleic, linoleic, and linolenic acids, as well as cyclopropenic fatty acids. Baobab also contains terpenoids, such as α- and β-amyrin palmitate, β-sitosterol, and ursolic acid.

Seed Oil Composition

Baobab seed oil is rich in oleic acid (~35%), linoleic acid (~30%), palmitic acid (~24%), and tocopherols (vitamin E).

Amino Acid Profile

Amino acid analyses of baobab reveal high glutamic and aspartic acid contents, with the sulfur-containing amino acids being the most limited amino acid.

4. Mechanisms of Action

Glycemic Regulation

Baobab polyphenols have been shown to act as natural enzyme inhibitors that reduce starch digestion, specifically through inhibition of alpha-amylase and alpha-glucosidase, which lowers the rate at which sugars are released during digestion.

Polyphenols are phytochemical compounds that have been shown to be effective as diabetic agents through the regulation of glucose homeostasis. Different mechanisms of action have been described, including insulin secretion improvement and glucagon-like-peptide (GLP-1) secretion, which stimulates postprandial insulin secretion.

Prebiotic / Fiber-Related Mechanisms

The prebiotic potential of baobab fruit pulp powder relates to its pectic polysaccharides with unique composition compared to other dietary sources, given that it is rich in low methoxylated homogalacturonan (HG). Baobab fiber may be complementary to other prebiotic fibers due to its relatively simple structure, facilitating breakdown in the proximal colon.

Antioxidant Activity

Baobab aqueous extract shows high total phenolic content and considerable proanthocyanidins and hydrolyzable tannins content. Moreover, baobab extract shows high antioxidant activity by FRAP, DPPH, and ABTS methods, as well as a high inhibition capacity of reactive oxygen and nitrogen species.

Anti-Inflammatory and Hepatoprotective Activity (Preclinical)

The fruit has anti-inflammatory, febrifuge, and analgesic properties due to the presence of saponins and sterols; experimental data have also shown the fruit to have hepatoprotective effects. The leaves have both antihypotensive and antihistaminic properties.

In animal models of inflammation, oral administration of baobab fruit pulp extracts reduced markers of systemic inflammation and oxidative stress. Rats administered baobab extract showed reduced paw edema in a carrageenan-induced inflammation model, with anti-inflammatory potency comparable to diclofenac at high doses. However, no published human clinical trial has examined the hepatoprotective effects of baobab supplementation in humans.

5. Scientific Evidence by Area of Use

5.1 Glycemic Response and Blood Sugar Regulation

Evidence strength: Preliminary human clinical evidence; small studies with healthy participants; no long-term or disease-specific RCTs published to date.

In a 2013 clinical study, researchers at Oxford Brookes University discovered that drinking a mix of baobab fruit powder and water significantly slowed the rise of blood sugar levels 20–60 minutes after eating high-glycemic-index white bread, as published in the journal Nutrition Research.

In a randomized controlled trial, participants consumed an aqueous drink containing baobab extract alongside white bread at two dose levels, 18.5 grams and 37 grams. The study found that baobab fruit extract lowered glycemic response at both doses compared with the control group.

Researchers also trialed different percentages of baobab fruit powder in a baking mix (1.25%, 1.88%, 2.50%, 3.13%, and 3.75%), and even the lowest amount proved effective in lowering the GI.

Baobab fruit appears to be effective on postprandial glycemia response, though scarce randomized clinical trials have been published. In one study, ingestion of aqueous baobab extract (0.1333 g Adansonia digitata/mL extract fresh weight) significantly reduced postprandial glycemia. A randomized controlled clinical trial was carried out in healthy adults ingesting the extract after an oral glucose tolerance test.

Coe et al. (2013) showed that baobab extracts significantly reduced starch breakdown in vitro, resulting in a decreased sugar release from white bread samples at 20 and 60 minutes, compared to control samples.

Importantly, existing trials have been conducted predominantly in healthy adult volunteers, are of short duration, and involve small sample sizes. No large-scale or long-term clinical trials in populations with type 2 diabetes or insulin resistance have been published, and efficacy in these populations remains unproven.

5.2 Gut Microbiota and Prebiotic Activity

Evidence strength: In vitro and ex vivo only; no published human feeding trials demonstrating microbiome or clinical health outcomes.

An exploratory study evaluated the prebiotic potential of baobab fruit pulp powder, which consists of pectic polysaccharides with unique composition compared to other dietary sources, given that it is rich in low methoxylated homogalacturonan (HG). After applying dialysis procedures to remove simple sugars from the product, 48-hour fecal batch incubations were performed.

Baobab fruit pulp powder boosted colonic acidification across three simulated human adult donors due to the significant stimulation of health-related metabolites acetate (+18.4 mM at 48 h), propionate (+5.5 mM at 48 h), and to a lesser extent butyrate (0.9 mM at 48 h). There was also a trend of increased lactate levels (+2.7 mM at 6 h) and reduced branched chain fatty acid (bCFA) levels.

A separate in vitro study using a validated Simulator of the Human Intestinal Microbial Ecosystem (SHIME®) was the first to highlight prebiotic activities of baobab fiber, finding that repeated administration of baobab fiber had a significant effect on the metabolic activity and microbial community composition of the gut microbiota.

Clinical human trials remain limited; current evidence establishes microbiota changes in controlled laboratory settings but requires validation for digestive health outcomes.

5.3 Iron Status and Anemia

Evidence strength: One small RCT with null primary endpoints; in vitro evidence of enhanced iron bioaccessibility.

Fruit pulp of the indigenous baobab tree contains significant amounts of vitamin C, which enhances non-heme iron bioavailability. Researchers studied the impact of baobab fruit pulp (BFP) consumption on the hemoglobin and iron status of Kenyan schoolchildren in a single-blind randomized controlled intervention trial among apparently healthy schoolchildren aged 6–12 years.

For 12 weeks, children in the intervention group (n = 29) received a drink with BFP, while the control group (n = 29) received an isoenergy drink without BFP. The development of hemoglobin, ferritin, and soluble transferrin receptor did not differ significantly between the intervention and control groups. However, in the intervention group, Hb levels improved slightly (2.2%), while they decreased slightly (1.2%) in the control group.

In vitro studies with baobab fruit pulp found significant improvements in iron bioaccessibility, probably due to the rich vitamin C content and other organic acids such as citric acid. The clinical RCT did not achieve statistical significance on its primary endpoints, limiting conclusions about baobab's effectiveness as a dietary intervention for iron deficiency anemia.

5.4 Antioxidant Activity

Evidence strength: Strong in vitro evidence; no published human clinical trials specifically measuring changes in oxidative stress biomarkers.

Baobab fruit pulp contains phenolic compounds (566.46–2529.25 mg GAE/100 g), and exhibits high antioxidant activity (FRAP: 1996.27–5861.33 mg FeSO4/100 g; DPPH: 49.19–98.33% inhibition; TAC: 8.17 g AAE/100 g).

Samples from the Virei municipality in Angola stood out for their high antioxidant activity (1936 mmol TE/100 g), high potassium content (42.4 mg/g), and higher protein values (2.42 g/100 g).

The high antioxidant activity of baobab could be due to polyphenols, such as proanthocyanidins and flavonol glycosides, identified in baobab fruit extracts.

5.5 Anti-inflammatory and Hepatoprotective Effects

Evidence strength: Animal model data only; no human clinical evidence.

Rats administered baobab extract showed reduced paw edema in a carrageenan-induced inflammation model, with anti-inflammatory potency comparable to diclofenac at high doses. Rats administered baobab extract also demonstrated hepatoprotective effects of baobab fruit pulp, reducing liver inflammation markers in a paracetamol-induced liver injury model. These findings are preclinical only.

5.6 Antimicrobial Activity

Evidence strength: In vitro laboratory evidence only.

Baobab fruit pulp, leaf, bark, and seed extracts have demonstrated antimicrobial activity against a range of pathogenic bacteria and fungi in laboratory studies. These findings have not been validated in human clinical studies.

5.7 Nutritional Supplementation and Deficiency Prevention

Baobab fruit is an important source of vitamin C and micronutrients including zinc, potassium, magnesium, iron, calcium, and protein, which may reduce nutritional deficiencies. The use of baobab leaves as a dietary supplement to combat micronutrient deficiencies in food-insecure populations in sub-Saharan Africa has been studied. The leaves of the baobab tree are a staple for many populations in Africa, especially in the central region of the continent; during the rainy season when the baobab leaves are tender, people harvest a fresh batch of leaves, and during the last month of the rainy season, leaves are harvested in great abundance and are dried for domestic use and for marketing during the dry season.

6. Body Systems and Health Areas of Association

• Gastrointestinal system: Prebiotic fiber activity, promotion of short-chain fatty acid production (acetate, propionate, butyrate), regulation of bowel function, and traditional use for diarrhea and dysentery.
• Metabolic and endocrine system: Postprandial glycemic response reduction via alpha-amylase/alpha-glucosidase inhibition and high-fiber bulking; potential relevance to type 2 diabetes risk management.
• Hematological system: Enhancement of non-heme iron absorption via high ascorbic acid and organic acid content.
• Immune and antioxidant system: High polyphenol and vitamin C content associated with free radical scavenging in vitro.
• Hepatic system: Preclinical (animal) evidence of hepatoprotective activity.
• Musculoskeletal/inflammatory system: Preclinical evidence for anti-inflammatory activity.
• Integumentary system: Baobab seed oil used topically in cosmetic and skin-care preparations.

7. Dosage Forms and Dosages Reported in Studies

Baobab is available commercially as:

• Dried fruit pulp powder (the most studied and regulated form)
• Aqueous extracts and beverages
• Capsules and tablets containing standardized fruit pulp powder
• Cold-pressed seed oil (topical and culinary)
• Leaf powder (regional food use, limited Western supplement use)

Dosages reported in published human clinical studies:

• In the randomized controlled trial on postprandial glycemic response, participants consumed an aqueous drink containing baobab extract alongside white bread at two dose levels: 18.5 grams and 37 grams.
• In a pilot-level clinical trial on glycemic response conducted at the Functional Food Centre of Oxford Brookes University, a milk drink containing 17.4 g of baobab powder was consumed by healthy human participants.
• In the 12-week Kenyan schoolchildren RCT on iron status, children in the intervention group received a daily drink with baobab fruit pulp. The specific per-dose amount of pulp powder is documented in the published paper (European Journal of Nutrition, 2021).

No standardized or pharmacopoeial dose for baobab as a dietary supplement has been established by any regulatory body. The dosages used across studies are not uniform, and the concentrations of bioactive compounds in commercial products may differ substantially from those used in trials, given the documented geographic variability in the fruit's composition.

8. Safety Considerations and Regulatory Status

Regulatory Approval

Since 2008, baobab fruit dried pulp has been listed as an ingredient on the European Union's Novel Food Catalogue. The U.S. legalized the import of baobab powder as a food and beverage ingredient in 2009, a year after the EU. The European Food Safety Authority (EFSA) lists baobab fruit alongside other traditional foods from third countries in its novel food assessments.

General Safety Profile

The long history of consumption of baobab fruit in African populations, and the novel food approval processes in the EU and the U.S. recognizing its safety as a food ingredient, support its general safety for use in foods at typical dietary doses. No significant adverse events attributable to baobab fruit pulp powder at food-level doses have been documented in the published clinical trial literature reviewed here.

Nutritional Composition Variability

There exist significant variations in pulp moisture, protein, fiber, ash, and elemental content among provenances. According to Monteiro et al. (2022), baobab nutritional composition, especially protein, sugar, and vitamin C content, can significantly differ according to different samples obtained in different locales. This means that standardization of bioactive content across commercial products is not guaranteed.

Gastrointestinal Effects

Due to the very high fiber content of baobab fruit pulp powder (reported up to 80% of dry mass in some analyses), high doses may cause gastrointestinal discomfort including bloating and increased flatulence, consistent with the well-characterized effects of any high-fiber supplement, particularly in individuals not accustomed to high fiber intakes.

Iron Absorption: A Dual Consideration

Vitamin C prevents the dose-dependent inhibitory effects of polyphenols and phytates on iron absorption, and further studies confirm vitamin C to enhance non-heme iron bioavailability. However, the high polyphenol content of baobab (tannins, proanthocyanidins) could also theoretically inhibit iron absorption if the ratio of polyphenol to iron is unfavorable. The net effect in human trials was modest and not statistically significant for primary endpoints.

Pregnancy and Lactation

The published peer-reviewed literature does not contain adequate human data to characterize the safety profile of baobab supplementation (as opposed to traditional food use) specifically during pregnancy or lactation. The food-level use of baobab in populations where it has been consumed for millennia is distinct from supplemental dosing.

Drug Interactions

No well-documented, clinically established drug interactions for baobab fruit pulp have been identified in the peer-reviewed literature reviewed here. The high vitamin C content has theoretical relevance to iron supplementation protocols and, at very high doses, to oxalate-related issues, consistent with well-known ascorbic acid pharmacology. The polyphenol content could theoretically affect the absorption of certain drugs or minerals if co-ingested, but no human pharmacokinetic interaction studies involving baobab specifically have been published.

References

• Nutritional variation in baobab (Adansonia digitata L.) fruit pulp and seeds based on Africa geographical regions — PMC
• Adansonia digitata L. (Baobab) Bioactive Compounds, Biological Activities, and the Potential Effect on Glycemia: A Narrative Review — PubMed
• Phytochemical Profile, Antioxidant and Antidiabetic Activities of Adansonia digitata L. (Baobab) from Mali — PMC
• Nutritional Properties of Baobab Pulp from Different Angolan Origins — PMC
• Chemical and nutrient analysis of baobab (Adansonia digitata) fruit and seed protein solubility — PubMed
• Baobab: The Tree of Life — An Ethnopharmacological Review — HerbalGram (American Botanical Council)
• Adansonia digitata L. (baobab): a review of traditional information and taxonomic description — Asian Pacific Journal of Tropical Biomedicine (ScienceDirect)
• The polyphenol-rich baobab fruit (Adansonia digitata L.) reduces starch digestion and glycemic response in humans — PubMed (Nutrition Research, 2013)
• Adansonia digitata L. (Baobab Fruit) Effect on Postprandial Glycemia in Healthy Adults: A Randomized Controlled Trial — Nutrients (MDPI)
• A Pectin-Rich, Baobab Fruit Pulp Powder Exerts Prebiotic Potential on the Human Gut Microbiome In Vitro — PMC (Microorganisms)
• Co-Supplementation of Baobab Fiber and Arabic Gum Synergistically Modulates the In Vitro Human Gut Microbiome — PMC
• Can the supplementary consumption of baobab (Adansonia digitata L.) fruit pulp improve hemoglobin levels and iron status of schoolchildren in Kenya? — PMC (European Journal of Nutrition)
• Baobab-Fruit Shell and Fibrous Filaments Are Sources of Antioxidant Dietary Fibers — PMC (Molecules)
• Nutritional, Antioxidant and Physicochemical Properties of Baobab (Adansonia Digitata L) Fruit Pulp from Cameroon — Journal of Food and Nutrition Sciences
• Adansonia digitata L. (Baobab) Bioactive Compounds, Biological Activities, and the Potential Effect on Glycemia — PMC (Nutrients, 2023)
• Baobab: Benefits, Forms, Dosing, and Side Effects — Dr Brad Stanfield (evidence-based review with cited primary literature)
• Novel food — European Food Safety Authority (EFSA)
• Evaluation of the Nutritional Impact of Baobab Leaves (Adansonia digitata L.) as a Dietary Intervention — Nutrients (MDPI, 2024)